5-Bromo-2′-deoxyuridine
SIGMA/B9285 - BioUltra, ≥99%
Synonym: 5-BrdU; 5-Bromo-1-(2-deoxy-β-D-ribofuranosyl)uracil; 5-Bromouracil deoxyriboside; BUdR
CAS Number: 59-14-3
Empirical Formula (Hill Notation): C9H11BrN2O5
Molecular Weight: 307.10
EC Number: 200-415-9
MDL Number: MFCD00006529
Linear Formula: C9H11BrN2O5
Product Type: Chemical
| assay | ≥99% |
| biological source | synthetic (organic) |
| cation traces | Al: ≤0.0005% |
| Ca: ≤0.01% | |
| Cu: ≤0.0005% | |
| Fe: ≤0.0005% | |
| K: ≤0.005% | |
| Mg: ≤0.0005% | |
| Na: ≤0.05% | |
| NH4+: ≤0.05% | |
| Pb: ≤0.001% | |
| Zn: ≤0.0005% | |
| form | powder |
| ign. residue | ≤0.1% |
| impurities | ≤0.005% Phosphorus (P) |
| ≤0.1% Insoluble matter | |
| InChI | 1S/C9H11BrN2O5/c10-4-2-12 |
| InChI key | WOVKYSAHUYNSMH-RRKCRQDMSA |
| mp | 191-194 °C (dec.) (lit.) |
| product line | BioUltra |
| Quality Level | 200 ![]() |
| SMILES string | OC[C@H]1O[C@H](C[C@@H]1O) |
| solubility | NH4OH: 0.1 M at 20 °C, clear, colorless |
| storage temp. | −20°C |
| Application: | 5-Bromo-2′-deoxyuridine has been used: • to label proliferating cells in pregnant mice in cell proliferation assay • to study the time course of cell proliferation at various times following ischemia, to confirm re-entry of MKI67+ cells in cell cycle to germ cells • in 5′-Bromo-2′Deoxyuridine (BrdUrd) staining of fibroblasts |
| Biochem/physiol Actions: | 5-Bromo-2′-deoxyuridine (5-BrdU) is a thymidine analogue which is incorporated into DNA. 5-BrdU is routinely and extensively used to measure DNA synthesis and to label dividing cells. Consequently 5-BrdU is used to study cell signaling and other processes that induce cell proliferation. |
| Biochem/physiol Actions: | 5′-Bromo-2-deoxyuridine (BrdU) staining is predominantly used to observe the multiplication of tumor cells and other tissues in vivo. |
| Biochem/physiol Actions: | Thymidine analog used as a mutagen in genetic research. Selectively incorporated into cellular DNA during S-phase. |
| General description: | 5′-Bromo-2-deoxyuridine (BrdU) is a carcinogen that may be absorbed by skin or inhalation. BrdU solutions are sensitive to light. |
| Other Notes: | 2024 CiteAb Award Winner for Supplier Succeeding in Parkinson′s Research ![]() |
| Packaging: | 1 g in poly bottle |
| Packaging: | 50, 250 mg in poly bottle |
| Symbol | GHS08 |
| Signal word | Danger |
| Hazard statements | H340 - H361fd |
| Precautionary statements | P201 - P202 - P280 - P308 + P313 - P405 - P501 |
| Hazard Codes | T |
| Risk Statements | 46-61 |
| Safety Statements | 53-45 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 2 |
| Purity | ≥99% |
| mp | 191-194 °C (dec.) (lit.) |
| Storage Temp. | −20°C |
| UNSPSC | 41106305 |


